|
|
||||||||
Radiology, Vol 187, 743-750, Copyright © 1993 by Radiological Society of North America
ARTICLES |
LP Adler, JP Crowe, NK al-Kaisi and JL Sunshine
Department of Radiology, University Hospitals of Cleveland, OH 44106.
Twenty-eight patients with a total of 35 suspect breast masses underwent positron emission tomography (PET) with [fluorine-18] 2-deoxy- 2-fluoro-D-glucose (FDG) in order to study the utility of this technique in the evaluation of breast cancer. FDG PET allowed discrimination between eight benign and 27 malignant breast masses, with a sensitivity of 96% and specificity of 100%. Among the malignancies, there was a significant correlation between normalized FDG uptake and nuclear grade (P = .006). In addition, the results of PET imaging were compared with results of axillary node dissection in 20 cases of breast cancer. PET allowed correct categorization of 10 of 10 axillae as negative (specificity = 100%). PET results were equivocal in one axilla and positive in the remaining nine of 10 axillae with positive dissection results (sensitivity = 90%). The authors conclude that FDG PET may give useful information on breast masses and axillary node status prior to surgery.
This article has been cited by other articles:
![]() |
D. J. A. Margolis, J. M. Hoffman, R. J. Herfkens, R. B. Jeffrey, A. Quon, and S. S. Gambhir Molecular Imaging Techniques in Body Imaging Radiology, November 1, 2007; 245(2): 333 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Lim, W. Yoon, T. W. Chung, J. K. Kim, J. G. Park, H. K. Kang, H. S. Bom, and J. H. Yoon FDG PET/CT for the Detection and Evaluation of Breast Diseases: Usefulness and Limitations RadioGraphics, October 1, 2007; 27(suppl_1): S197 - S213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mavi, T. F. Cermik, M. Urhan, H. Puskulcu, S. Basu, J. Q. Yu, H. Zhuang, B. Czerniecki, and A. Alavi The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on 18F-FDG Uptake of Primary Breast Cancer Lesions J. Nucl. Med., August 1, 2007; 48(8): 1266 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mavi, M. Urhan, J. Q. Yu, H. Zhuang, M. Houseni, T. F. Cermik, D. Thiruvenkatasamy, B. Czerniecki, M. Schnall, and A. Alavi Dual Time Point 18F-FDG PET Imaging Detects Breast Cancer with High Sensitivity and Correlates Well with Histologic Subtypes J. Nucl. Med., September 1, 2006; 47(9): 1440 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chung, D. Liou, S. Karlan, A. Waxman, K. Fujimoto, M. Hagiike, and E. H. Phillips Preoperative FDG-PET for Axillary Metastases in Patients With Breast Cancer Arch Surg, August 1, 2006; 141(8): 783 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, V. A. Loving, A. Chauhan, H. Zhuang, S. Mitchell, and A. Alavi Potential of Dual-Time-Point Imaging to Improve Breast Cancer Diagnosis with 18F-FDG PET J. Nucl. Med., November 1, 2005; 46(11): 1819 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Quon and S. S. Gambhir FDG-PET and Beyond: Molecular Breast Cancer Imaging J. Clin. Oncol., March 10, 2005; 23(8): 1664 - 1673. [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, S.-k. Kim, E. S. Lee, J. Ro, and S. h. Kang Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy Ann. Onc., September 1, 2004; 15(9): 1352 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lovrics, V. Chen, G. Coates, S. D. Cornacchi, C. H. Goldsmith, C. Law, M. N. Levine, K. Sanders, and V. R. Tandan A Prospective Evaluation of Positron Emission Tomography Scanning, Sentinel Lymph Node Biopsy, and Standard Axillary Dissection for Axillary Staging in Patients with Early Stage Breast Cancer Ann. Surg. Oncol., September 1, 2004; 11(9): 846 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Rohren, T. G. Turkington, and R. E. Coleman Clinical Applications of PET in Oncology Radiology, May 1, 2004; 231(2): 305 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J.M. van der Hoeven, N. C. Krak, O. S. Hoekstra, E. F.I. Comans, R. P.A. Boom, D. van Geldere, S. Meijer, E. van der Wall, J. Buter, H. M. Pinedo, et al. 18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging of Locally Advanced Breast Cancer J. Clin. Oncol., April 1, 2004; 22(7): 1253 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kapoor, B. M. McCook, and F. S. Torok An Introduction to PET-CT Imaging RadioGraphics, March 1, 2004; 24(2): 523 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Wahl, B. A. Siegel, R. E. Coleman, and C. G. Gatsonis Prospective Multicenter Study of Axillary Nodal Staging by Positron Emission Tomography in Breast Cancer: A Report of the Staging Breast Cancer With PET Study Group J. Clin. Oncol., January 15, 2004; 22(2): 277 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Shetty and W. S. Carpenter Sonographic Evaluation of Isolated Abnormal Axillary Lymph Nodes Identified on Mammograms J. Ultrasound Med., January 1, 2004; 23(1): 63 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vranjesevic, C. Schiepers, D. H. Silverman, A. Quon, J. Villalpando, M. Dahlbom, M. E. Phelps, and J. Czernin Relationship Between 18F-FDG Uptake and Breast Density in Women with Normal Breast Tissue J. Nucl. Med., August 1, 2003; 44(8): 1238 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Levine, R. I. Freimanis, N. D. Perrier, K. Morton, N. M. Lesko, S. Bergman, K. R. Geisinger, R. C. Williams, C. Sharpe, V. Zavarzin, et al. Positron Emission Mammography: Initial Clinical Results Ann. Surg. Oncol., January 1, 2003; 10(1): 86 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Liu, Y.-Y. Shen, C.-C. Lin, R.-F. Yen, and C.-H. Kao Clinical Impact of [18F]FDG-PET in Patients with Suspected Recurrent Breast Cancer Based on Asymptomatically Elevated Tumor Marker Serum Levels: a Preliminary Report Jpn. J. Clin. Oncol., July 1, 2002; 32(7): 244 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Charvolin, R. J. Salmon, A. Pecking, and V. Mareschal Positron Emission Tomography Detection of Breast Cancer Metastasis to the Uterus Obstet. Gynecol., May 1, 2002; 99(5): 915 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Nabi and J. M. Zubeldia Clinical Applications of 18F-FDG in Oncology J. Nucl. Med. Technol., March 1, 2002; 30(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vranjesevic, J. E. Filmont, J. Meta, D. H. Silverman, M. E. Phelps, J. Rao, P. E. Valk, and J. Czernin Whole-Body 18F-FDG PET and Conventional Imaging for Predicting Outcome in Previously Treated Breast Cancer Patients J. Nucl. Med., March 1, 2002; 43(3): 325 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A D Murray, R T Staff, T W Redpath, F J Gilbert, A K Ah-See, J A Brookes, I D Miller, and S Payne Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes Br. J. Radiol., March 1, 2002; 75(891): 220 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Yap, M. A. Seltzer, C. Schiepers, S. S. Gambhir, J. Rao, M. E. Phelps, P. E. Valk, and J. Czernin Impact of Whole-Body 18F-FDG PET on Staging and Managing Patients with Breast Cancer: The Referring Physician's Perspective J. Nucl. Med., September 1, 2001; 42(9): 1334 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF] |
||||
![]() |
M. Greco, F. Crippa, R. Agresti, E. Seregni, A. Gerali, R. Giovanazzi, A. Micheli, S. Asero, C. Ferraris, M. Gennaro, et al. Axillary Lymph Node Staging in Breast Cancer by 2-Fluoro-2-deoxy-D-glucose-Positron Emission Tomography: Clinical Evaluation and Alternative Management J Natl Cancer Inst, April 18, 2001; 93(8): 630 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uematsu, M. Sano, and K. Homma In Vitro High-Resolution Helical CT of Small Axillary Lymph Nodes in Patients with Breast Cancer: Correlation of CT and Histology Am. J. Roentgenol., April 1, 2001; 176(4): 1069 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Yang, S. J. Nam, T. S. Lee, H. K. Lee, S. H. Jung, and B. T. Kim Comparison of Intraoperative Frozen Section Analysis of Sentinel Node with Preoperative Positron Emission Tomography in the Diagnosis of Axillary Lymph Node Status in Breast Cancer Patients Jpn. J. Clin. Oncol., January 1, 2001; 31(1): 1 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Avril, M. Menzel, J. Dose, M. Schelling, W. Weber, F. Janicke, W. Nathrath, and M. Schwaiger Glucose Metabolism of Breast Cancer Assessed by 18F-FDG PET: Histologic and Immunohistochemical Tissue Analysis J. Nucl. Med., January 1, 2001; 42(1): 9 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Avril, C. A. Rose, M. Schelling, J. Dose, W. Kuhn, S. Bense, W. Weber, S. Ziegler, H. Graeff, and M. Schwaiger Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations J. Clin. Oncol., October 20, 2000; 18(20): 3495 - 3502. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Yang, J. Chang, and C. Metreweli Patients with Breast Cancer: Differences in Color Doppler Flow and Gray-Scale US Features of Benign and Malignant Axillary Lymph Nodes Radiology, May 1, 2000; 215(2): 568 - 573. [Abstract] [Full Text] |
||||
![]() |
M. Schelling, N. Avril, J. Nahrig, W. Kuhn, W. Romer, D. Sattler, M. Werner, J. Dose, F. Janicke, H. Graeff, et al. Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer J. Clin. Oncol., April 1, 2000; 18(8): 1689 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Berger, S. A. Nicholson, F. Dehdashti, and B. A. Siegel FDG PET Evaluation of Mucinous Neoplasms: Correlation of FDG Uptake with Histopathologic Features Am. J. Roentgenol., April 1, 2000; 174(4): 1005 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Hathaway, D. A. Mankoff, K. R. Maravilla, M. M. Austin-Seymour, G. K. Ellis, J. R. Gralow, A. A. Cortese, C. E. Hayes, and R. E. Moe Value of Combined FDG PET and MR Imaging in the Evaluation of Suspected Recurrent Local-Regional Breast Cancer: Preliminary Experience Radiology, March 1, 1999; 210(3): 807 - 814. [Abstract] [Full Text] |
||||
![]() |
V. J Lowe and K. S Naunheim Current role of positron emission tomography in thoracic oncology Thorax, August 1, 1998; 53(8): 703 - 712. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |